URGN UROGEN PHARMA LTD
FollowCOMMON STOCK (common), issuer CIK 1668243
Filings received so far for Q3 2026: 6 13F filers report a position in URGN shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.
13D and 13G filers
No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.
Insider trades
| Owner | Date | Shares | Price | Filing |
|---|---|---|---|---|
| Degnan Chrisofficer (Chief Financial Officer) | 2026-10-08 | -2,202 S | $36.69 | Form 4 |
| Degnan Chrisofficer (Chief Financial Officer) | 2026-10-08 | +4,483 M | Form 4 |
13F holders, Q3 2026
Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| Hennion & Walsh Asset Management, Inc. | 309,584 | $12.6M | 0.37% | +32,888 | 13F-HRTimeline |
| WEALTH ENHANCEMENT ADVISORY SERVICES, L… | 20,291 | $750K | <0.01% | +12,649 | 13F-HRTimeline |
| GAMMA Investing LLC | 664 | $27K | <0.01% | +223 | 13F-HRTimeline |
| BEACON INVESTMENT ADVISORY SERVICES, IN… | 250 | $10.2K | <0.01% | new | 13F-HRTimeline |
| Farther Finance Advisors, LLC | 82 | $3.33K | <0.01% | +58 | 13F-HRTimeline |
| True Wealth Design, LLC | 17 | $691 | <0.01% | +1 | 13F-HRTimeline |
Events
Degnan Chris acquired 2,281 URGN shares on 2026-10-08, Form 4 filed 2026-10-09. 0001437749-26-032421
Accepted , ingested